• Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page

buyout

  1. Amgen revisiting Akebia buyout

    Amgen BD looking to salvage the revenue being lost from its EPO business. Both Vifor and Davita (converting fast from Epogen to Mircera) are using Roche product. Its best and the only option is Vafseo, which also has better labeling than GSK oral product, and also touts existing partnership with...
  2. Pension - Lump Sum Buyout Offer

    I was laid off by J&J last year (2018), after 15+ years. Happened in my early 50s, which is typical J&J procedure, to avoid paying full pension / healthcare benefits at 55. I received an offer in the mail from J&J to receive a Lump Sum Pension Buyout. Anyone know how that is calculated? I...
  3. Pipeline saved with cheap buyout

    seems the executive teams for Biogen and Zosano have been meeting a lot as of late.. backfilling that empty pipeline. apparently a quarter of funds earmarked for the 1 billion stock buyback will actually go towards acquiring this migraine therapy in a cash and stock deal. Being scooped up...
  4. Buy Out ?

    So the rumormill is churning about potential bid coming from Pfizer. Have any employees heard any rumblings about this yet?
  5. Bristol-Myers Squibb swallows Celgene for $74 billion

    Bristol-Myers Squibb acquires Celgene for $74 billion. Celgene stock surges while BMY plunges. 2019 starts well for Celgene. More M&As are in the pipeline in the biopharma space.
  6. Onconova and it’s Phase 3 - Positive

    Anybody else hearing chatter within any of the larger Pharma shopping around. Hearing very promising results
  7. Juno buyout buzz becomes true

    It's an M&A Monday for the pharma companies. Two major pharma acquisitions announced today. 1) Celgene acquires Juno for $9 billion http://alph.st/pd7bf702 2) Sanofi acquires Bioverative for $11.6 billion Last week, there was a rumor that Celgene's acquisition of Juno and also news about...
  8. Will Celgene buy Juno?

    Yesterday, WSJ has stated that Celgene is holding talks to acquire Juno Therapeutics. http://alph.st/pd7bf702 Will this move strengthen Celgene? In 2018, the first acquisition was Impact and now the unconfirmed Juno hunting.
  9. A bad move by Allergan

    I don't know why Allergan is buying this struggling penny stock company. I don't think Allergan can do what Repros couldn’t and deliver the safety data that the FDA is looking for.
  10. Amedica and Zimmer soon to be one

    Told you all this was going to happen. Amedicas 10k out today. Check my blog for updates as today is the start of it all! Find constant updates here and here. https://stocktwits.com/symbol/AMDA https://investorshub.advfn.com/Amedica-Corp-AMDA-27931/
  11. Clovis Oncology buyout true?

    Rumors say that Lilly to acquire Clovis Oncology.
  12. Taro Pharma buyout by Sun Pharma

    Taro is being run by Sun but it is still an independent company. Has anyone heard of the rumors that Sun will be buying out the remaining stake in Taro? Taro is run by Sun but if the buyout happens, what will happen? Should we be worried?
  13. Immune Pharma merging??? IMNP

    Word on the street is that immune pharma (IMNP) is im talks to merge with a big pharma, maybe allergan. They canceled their lease and paid a significant six figure penalty to get out of it. It doesn't appear they have much of a company left, just an interim CEO to handle the transition...